News

The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...
In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...
A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...
HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.
HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).
Africa Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...